These guidelines are for the general public and in particular persons intending to obtain a permit to clear restricted chemicals and agrochemicals. They prescribe the requirement for documentation, processing, personnel requirement, and timeline for obtaining permit.

This document gives a report on the Executive Order 001 (EO1) signed on 18 May, 2017, by Vice President, Professor Yemi Osibajo (SAN), then Acting President. This first executive order of Buhari’s administration has been acknowledged as one of the Federal Government of Nigeria (FGN)’s most innovative strategic initiatives to deliver quick, pragmatic changes for Nigerians. Its objective is to promote transparency and efficiency in the business environment.

This guideline document is for those importers of bulk food raw materials / importers of frozen fish, for which NAFDAC permits or certificate of registration are not issued, who require authorization to open form M.

This document provides the implementation guidelines for containment of COVID-19 by the Federal Government of Nigeria at different phases of COVID-19 response measures. This is to curb the spread of coronavirus in the work environments.

These guidelines are for the interest of the general public and in particular to marketers of pesticides, agrochemicals, fertilizers, bio-pesticides and bio-fertilizers in Nigeria. It emphasizes that no importation shall be made by any importer of pesticides, agrochemicals, fertilizers bio-pesticides and bio-fertilizers without obtaining listing certificate as a pesticide and agrochemical marketer from NAFDAC except in accordance with the provisions of NAFDAC Act CAP N1 (LFN) 2004, other related Legislations and the accompanying guidelines.

These guidelines prescribe the minimum Good Manufacturing Practice (GMP) requirements for the facilities and controls to be used in the manufacture of products approved for this scheme to ensure quality and safety of the products. It states that regulated products should not be manufactured in Nigeria unless the facility has been inspected and a Certificate of Recognition as a manufacturer is issued by NAFDAC. The document highlights the only products to be manufactured and how to apply for inspection.

This document outlines the guidelines on re-opening places of worship during the COVID-19 outbreak.

This guideline document is for the interest of the general public and in particular, holders of NAFDAC certificate of registration for regulated products, who may wish to grant authorization (No objection) for the importation of their registered products by another company.

These guidelines are intended to provide guidance on the technical and other general data requirements when submitting an application for renewal of product licence for imported medical devices. It outlines the process to be followed and the technical requirements to be met before a product can be placed on the Nigerian market.

These guidelines are for the interest of the general public and in particular importers of donated products into Nigeria. The document provides information on the documentation for clearance, physical examination, and release of the consignment from the port of entry.

These guidelines are for the interest of the general public and in particular, importers of finished bulk food, food raw materials and animal feed into Nigeria. The document emphasizes that no finished bulk food and/or food raw materials should be imported without obtaining Import Permit. It also provides for payment, submission of documents for first endorsement, joint inspection of consignment, second endorsement, release of consignment and tariff.

These guidelines are developed for the interest of the general public and in particular, importers of Narcotic and Controlled Substances, Pharmaceutical raw materials and restricted chemicals into Nigeria. The document emphasizes that pharmaceutical raw materials and restricted chemicals should not be imported without obtaining Import permit and permit to clear where applicable.

These guidelines are for the interest of the general public and in particular importers of finished pharmaceutical, nutraceutical and herbal products (Human and Veterinary) into Nigeria. The document provides for payment, submission of documents for first endorsement, first endorsement, and joint inspection of consignment, second endorsement and release of consignment.

These guidelines are for the interest of the general public and in particular, importers of food products into Nigeria. The document provides the procedures for application, verification of application, payment, submission of application, review of application, first endorsement, joint inspection of consignment, second endorsement, release of consignment and tariff.

These guidelines are for the interest of the general public and in particular, importers of cosmetics and medical devices into Nigeria. The document emphasizes that no cosmetics and medical devices shall be manufactured, imported, exported, advertised, sold, distributed or used in Nigeria unless it has been registered in accordance with the provisions of National Agency for Food and Drug Administration and Control (NAFDAC) Act CAP N1 (LFN) 2004, other related legislations and the accompanying guidelines.

These guidelines are for the interest of the general public and in particular importers of general chemicals, agrochemicals and raw materials into Nigeria. The document emphasizes that no general chemicals, agrochemicals or raw materials shall be imported without obtaining an Import permit or approval. It provides for payment, submission of documents for first endorsement, joint inspection of consignment, second endorsement and release of consignment.

These guidelines are for the interest of the general public and in particular individuals and organizations intending to conduct clinical trials in Nigeria. This document emphasizes that no person shall import, procure or manufacture a drug product, cosmetic or medical device for the purpose of a clinical test in Nigeria unless he is a holder of a valid clinical trial approval and the trial is to be conducted in accordance with the terms of the approval and the provisions of any regulations in force.

The guideline has an overall objective to encourage and facilitate timely paediatric medicinal product development in Nigeria. It provides an outline of critical issues in paediatric drug development and the approaches to the safe, efficient and ethical study of medicinal products in the paediatric population.

These guidelines are for the interest of the general public and in particular individuals and organizations intending to submit progress reports of ongoing clinical trials in Nigeria. The document emphasizes that progress reports on ongoing clinical trials in Nigeria should be submitted using the report template in This guideline.

This document defines the terms “objective” and “study endpoint”. It clearly states that for purposes of registration and reporting, the terms objectives and endpoints as used in this template provided in this document align with the terms primary purpose and outcome measures in clinicaltrials.gov, respectively. Individuals should provide a description of the study objectives and endpoints, as well as a justification for selecting the particular endpoints, in the table format included in the statement of compliance 3.0 of the document. This will provide clear articulation on how the selected primary and secondary endpoint(s) are linked to achieving the primary and secondary objectives and an explanation of why endpoint(s) were chosen. Data points collected in the study should support an objective or have a regulatory purpose. Therefore, careful consideration should be given prospectively to the amount of data needed to support the study’s objectives.